Results 171 to 180 of about 19,271 (221)

Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes? [PDF]

J Endocrinol
Lafferty RA, Flatt PR, Gault VA, Irwin N.   +3 more
europepmc   +1 more source

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists. [PDF]

Cochrane Database Syst Rev
Grenet G, Gougeon A, Salzwedel DM, Jauca CD, Wright JM.   +4 more
europepmc   +1 more source

Glucose-dependent insulinotropic polypeptide receptor systems in the hypothalamus and the brainstem regulate feeding and weight through distinct pathways. [PDF]

J Diabetes Investig
Yada T.
europepmc   +1 more source

DPP4 in diabetes [PDF]

, 2015
Diana Röhrborn
core   +1 more source

Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation. [PDF]

Int J Mol Sci
Terasaki M, Yashima H, Mori Y, Saito T, Inoue N, Matsui T, Osaka N, Fujikawa T, Ohara M, Yamagishi SI.   +9 more
europepmc   +1 more source

G protein-coupled receptors as new therapeutic targets for type 2 diabetes [PDF]

, 2015
Fiona M. Gribble, Frank Reimann
core   +1 more source

Skeletal Muscle Mass and Body Weight Fall Proportionally With Use of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist Tirzepatide: Case Report and Review of Literature. [PDF]

AACE Clin Case Rep
Zinn J, Poretsky L.
europepmc   +1 more source

Gastrointestinal effects of extra-virgin olive oil associated with lower postprandial glycemia in type 1 diabetes [PDF]

, 2019
Alderisio, Antonio, Annuzzi, Giovanni, Barone, Francesca, Bozzetto, Lutgarda, Cipriano, Paola, Clemente, Gennaro, Costabile, Giuseppina, Giacco, Angela, Giorgini, Marisa, Griffo, Ettore, Riccardi, Gabriele, Rivellese, Angela Albarosa, Vetrani, Claudia   +12 more
core   +1 more source

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update. [PDF]

Endocrinol Metab (Seoul)
Jakubowska A, Roux CWL, Viljoen A.
europepmc   +1 more source

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis. [PDF]

Addiction
Qeadan F, McCunn A, Tingey B.
europepmc   +1 more source